Table 3. Subgroup analysis of HR in overall survival (OS).
| Analysis | No. of studies | No.of patients | HR(95% CI) | P value | Model | Heterogeneity | |
|---|---|---|---|---|---|---|---|
| I2 (%) | P | ||||||
| Subgroup1: patient origin | |||||||
| China | 11 | 1062 | 0.357 (0.286–0.445) | < 0.001 | Fixed-effect | 0.0% | 0.713 |
| Non-China | 6 | 721 | 0.605 (0.410–0.895) | 0.012 | Random-effect | 79% | < 0.001 |
| Subgroup 2 tumor types | |||||||
| Nervous system | 3 | 1097 | 0.888 (0.399–1.974) | 0.771 | Random-effect | 92% | < 0.001 |
| Head and neck squamous cell carcinoma | 3 | 571 | 0.504 (0.177–1.440) | 0.206 | Random-effect | 90% | < 0.001 |
| Respiratory system | 6 | 1051 | 0.666 (0.557–0.797) | < 0.001 | Fixed-effect | 25% | 0.249 |
| Gastrointestinal system | 14 | 1798 | 0.674 (0.510–0.892) | 0.006 | Random-effect | 78% | < 0.001 |
| Urinary and reproductive system | 6 | 1995 | 0.720 (0.505–1.025) | 0.068 | Random-effect | 78% | < 0.001 |